Abstract
In this modern age of in-depth molecular and genetic focus on diseases, it is pressing that we revisit the fundamental pathology underlying chronic pulmonary obstructive diseases—forgetting the past limits our ability to make the best from the present. This review seeks to integrate when possible what is known about the pathology of COPD with key pathogenetic data. However, to move the field forward, investigators dedicated to COPD are required to understand the normal and diseased lung structure (qualitatively and quantitatively), including on how best determine these key parameters; there was a time, approximately more than a half a decade ago, in which these were the most exciting and hopeful developments to understand COPD. They form the foundation to better appreciate the challenge to understand COPD and, most importantly, give proper credit to key studies that, in the past 50 years, shaped our current understanding of this highly challenging disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Thurlbeck WM. Chronic airflow obstructions: correlation of structure and function. In: Petty TL, editor. Chronic obstructive pulmonary disease. New York: Marcel Decker; 1985. p. 129–203.
Mitchell RS, Toll G, Filley GF. The early lesions in pulmonary emphysema. Am J Med Sci. 1962;243:409–19.
Snider GL, Kleinerman LJ, Thurlbeck WM, Bengali ZH. The definition of emphysema: report of a National, Heart, Lung and Blood Institute. Division of Lung Diseases Workshop. Am Rev Respir Dis. 1985:182–5.
Thurlbeck WM. The internal surface area of nonemphysematous lungs. Am Rev Respir Dis. 1967;95:765–73.
Thurlbeck WM. Post-mortem lung volumes. Thorax. 1979;34:735–9.
Weibel ER, Gomez DM. Architecture of the human lung. Use of quantitative methods establishes fundamental relations between size and number of lung structures. Science. 1962;137:577–85.
Ochs M, Nyengaard JR, Jung A, Knudsen L, Voigt M, Wahlers T, Richter J, Gundersen HJ. The number of alveoli in the human lung. Am J Respir Crit Care Med. 2004;169:120–4.
Tuder RM, Stacher E, Robinson J, Kumar R, Graham BB. Pathology of pulmonary hypertension. Clin Chest Med. 2013;34:639–50.
Weibel ER. A retrospective of lung morphometry: from 1963 to present. Am J Physiol Lung Cell Mol Physiol. 2013;305:L405–8.
Verbeken EK, Cauberghs M, Mertens I, Clement J, Lauweryns JM, van de Woestijne KP. The senile lung. Comparison with normal and emphysematous lungs. 1. Structural aspects. Chest. 1992;1992(101):793–9.
Verbeken EK, Cauberghs M, Lauweryns JM, van de Woestijne KP. Anatomy of membranous bronchioles in normal, senile and emphysematous human lungs. J Appl Physiol. 1994;1994(77):1875–84.
Weibel ER. Design and structure of human lung. In: Fishman AP, editor. Pulmonary diseases and disorders. New York: McGraw-Hill; 1980. p. 224–81.
Thurlbeck WM. Internal surface area and other measurements in emphysema. Thorax. 1967;22:483–96.
Horsfield K. Quantitative morphology and structure: functional correlations in the lung. Monogr Pathol. 1978;19:151–9.
Matsuba K, Thurlbeck WM. The number and dimensions of small airways in emphysematous lungs. Am J Pathol. 1972;67:265–75.
Crapo JD, Young SL, Fram EK, Pinkerton KE, Barry BE, Crapo RO. Morphometric characteristics of cells in the alveolar region of mammalian lungs. Am Rev Respir Dis. 1983;128:S42–6.
Herring MJ, Putney LF, Wyatt G, Finkbeiner WE, Hyde DM. Growth of alveoli during postnatal development in humans based on stereological estimation. Am J Physiol Lung Cell Mol Physiol. 2014;307:L338–44.
Hsia CC, Hyde DM, Ochs M, Weibel ER. An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. Am J Respir Crit Care Med. 2010;181:394–418.
Liebow AA, Gough J. Pulmonary emphysema with special reference to vascular changes. Am Rev Respir Dis. 1959;80:67–93.
Tuder RM, Yoshida T, Fijalkowka I, Biswal S, Petrache I. Role of lung maintenance program in the heterogeneity of lung destruction in emphysema. Proc Am Thorac Soc. 2006;3:673–9.
Thurlbeck WM. Internal surface area of normal and emphysematous lungs. Aspen Emphysema Conf. 1967;10:379–93.
Verbeken EK, Cauberghs M, Mertens I, Lauweryns JM, van de Woestijne KP. Tissue and airway impedance of excised normal, senile, and emphysematous lungs. J Appl Physiol. 1992;72:2343–53.
Reid LM. Pathology of chronic bronchitis. Lancet. 1956:275–81.
Reid LM. Pathology of chronic bronchitis. Lancet. 1954;266:274–8.
Dunnill MS, Ryder R. A quantitative study of the relationship between chronic bronchitis, emphysema and smoking. Chest 1971;59: Suppl 35S+.
Bedrossian CW, Anderson AE Jr, Foraker AG. Bronchial morphometry in emphysema and senescence. Exp Mol Pathol. 1977;27:44–50.
Thurlbeck WM. The pathology of small airways in chronic airflow limitation. Eur J Respir Dis Suppl. 1982;121:9–18.
Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278:1355–60.
Leopold JG, Gough J. The centrilobular form of hypertrophic emphysema and its relation to chronic bronchitis. Thorax. 1957;12:219–35.
Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2645–53.
Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256–76.
McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO, Pare PD, Sin DD, Pierce RA, Woods JC, McWilliams AM, Mayo JR, Lam SC, Cooper JD, Hogg JC. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365:1567–75.
Nagai A, Yamawaki I, Takizawa T, Thurlbeck WM. Alveolar attachments in emphysema of human lungs. Am Rev Respir Dis. 1991;144:888–91.
Saito K, Cagle P, Berend N, Thurlbeck WM. The "destructive index" in nonemphysematous and emphysematous lungs. Morphologic observations and correlation with function. Am Rev Respir Dis. 1989;1989(139):308–12.
Saetta M, Shiner RJ, Angus GE, Kim WD, Wang NS, King M, Ghezzo H, Cosio MG. Destructive index: a measurement of lung parenchymal destruction in smokers. Am Rev Respir Dis. 1985;131:764–9.
Nagai A, Inano H, Matsuba K, Thurlbeck WM. Scanning electronmicroscopic morphometry of emphysema in humans. Am J Respir Crit Care Med. 1994;150:1411–5.
Wright GW, Kleinerman J. The J. Burns Amberson Lecture: A consideration of the etiology of emphysema in terms of contemporary knowledge. Am Rev Respir Dis 1963; 88: 605–620
Hyde DM, Harkema JR, Tyler NK, Plopper CG. Design-based sampling and quantitation of the respiratory airways. Toxicol Pathol. 2006;34:286–95.
Dunnill MS. Evaluation of a simple method of sampling for quantitative histological analysis. Thorax. 1964;19:443–8.
Dunnill MS. Quantitative methods in the study of pulmonary pathology. Thorax. 1962;17:320–8.
Thurlbeck WM, Dunnill MS, Hartung W, Heard BE, Heppleston AG, Ryder RC. A comparison of three methods of measuring emphysema. Hum Pathol. 1970;1:215–26.
Dunnill MS. The recognition and measurement of pulmonary emphysema. Pathol Microbiol (Basel). 1970;35:138–45.
Dunnill MS. Quantitative observations on the anatomy of chronic non-specific lung disease. Med Thorac. 1965;22:261–74.
Thurlbeck WM. Measurement of pulmonary emphysema. Am Rev Respir Dis. 1967;95:752–64.
Schmidt RA, Glenny RW, Godwin JD, Hampson NB, Cantino ME, Reichenbach DD. Panlobular emphysema in young intravenous Ritalin abusers. Am Rev Respir Dis. 1991;143:649–56.
Kim WD, Eidelman DH, Izquierdo JL, Ghezzo H, Saetta MP, Cosio MG. Centrilobular and panlobular emphysema in smokers. Two distinct morphologic and functional entities. Am Rev Respir Dis. 1991;144:1385–90.
Vlahovic G, Russell ML, Mercer RR, Crapo JD. Cellular and connective tissue changes in alveolar septal walls in emphysema. Am J Respir Crit Care Med. 1999;160:2086–92.
West WW, Nagai A, Hodgkin JE, Thurlbeck WM. The National Institutes of Health Intermittent Positive Pressure Breathing trial—pathology studies. III. The diagnosis of emphysema. Am Rev Respir Dis. 1987;135:123–9.
Hogg JC, Wright JL, Wiggs BR, Coxson HO, Opazo SA, Pare PD. Lung structure and function in cigarette smokers. Thorax. 1994;49:473–8.
Magee F, Wright JL, Wiggs BR, Pare PD, Hogg JC. Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax. 1988;43:183–9.
Scott KW. Quantitation of thick-walled peripheral lung vessels in chronic airways obstruction. Thorax. 1976;31:315–9.
Horsfield K, Thomas M. Morphometry of pulmonary arteries from angiograms in chronic obstructive lung disease. Thorax. 1981;36:360–5.
Barbera JA, Riverola A, Roca J, Ramirez J, Wagner PD, Ros D, Wiggs BR, Rodriguez-Roisin R. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994;149:423–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Tuder, R.M. (2017). Pathology of Chronic Obstructive Pulmonary Diseases. In: Lee, SD. (eds) COPD. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47178-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-662-47178-4_3
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-47177-7
Online ISBN: 978-3-662-47178-4
eBook Packages: MedicineMedicine (R0)